Stay updated on Personalized Neoantigen Cancer Vaccine Clinical Trial
Sign up to get notified when there's something new on the Personalized Neoantigen Cancer Vaccine Clinical Trial page.

Latest updates to the Personalized Neoantigen Cancer Vaccine Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedFDA-regulated product disclosures and a large set of drug/MeSH terms (including ipilimumab and nivolumab) were deleted. The deletions reduce visibility of the study’s immunotherapy components and regulatory context on the page.SummaryDifference19%

- Check19 days agoChange DetectedRevision tag updated from v3.6.6 to v3.7.0, indicating a new page build/version. This change represents a metadata update and does not modify study content or user-facing information.SummaryDifference0.0%

- Check33 days agoChange DetectedA minor version update was applied, changing the page revision from v3.6.5 to v3.6.6. The visible content and study details remain unchanged.SummaryDifference0.0%

- Check54 days agoChange DetectedThe revision badge on the page has been updated from v3.6.4 to v3.6.5, representing a small software version update. It does not modify study details or visible content.SummaryDifference0.0%

- Check69 days agoChange DetectedThe page now displays Revision: v3.6.4, indicating a minor site maintenance or metadata update rather than a substantive change to study details.SummaryDifference0.0%

- Check90 days agoChange DetectedThe page displays the updated revision tag v3.6.3, replacing v3.6.2. This represents a minor site update to the study page and does not alter study content or data.SummaryDifference0.0%

Stay in the know with updates to Personalized Neoantigen Cancer Vaccine Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Personalized Neoantigen Cancer Vaccine Clinical Trial page.